News in vaccination against pneumococcal disease

Autori:

Marija Kusulja, Neven Miculinić, Miroslav Samaržija, Marija Santini, Lorna Stemberger Marić, Andrea Vukić Dugac

Sažetak
Streptococcus pneumoniae važan je i čest uzročnik teških bolesti u svim, a osobito u krajnjim dobnim skupinama. Cijepljenje je najvažnija mjera prevencije pneumokokne bolesti u svih osoba, a posebice u određenih rizičnih skupina. U ovom su radu sažeti epidemiologija pneumokokne bolesti, dosadašnje prakse cijepljenja pneumokoknim konjugiranim cjepivom (PCV) i pneumokoknim polisaharidnim cjepivom (PPSV) te informacije o novodostupnim konjugiranim cjepivima. U radu se predlaže redoslijed i izbor cjepiva ovisno o dobi i pripadnosti određenoj rizičnoj skupini.
Summary

Streptococcus pneumoniae is an important and common cause of serious illnesses in all age groups, especially in the extremes of age. Vaccination is the most important measure in prevention of pneumococcal diseases in all people, particularly those within certain risk groups. This paper reviews epidemiology of pneumococcal disease, current practices in vaccination with pneumococcal conjugate vaccine (PCV) and pneumococcal polysaccharride vaccine (PPSV), and information on newly available 20-valent conjugated vaccine.

The paperrecommends the sequence and choice of vaccine based on age and belonging to a particular risk group.

Volumen: 7-8, 2025

Liječ Vjesn 2025;147:303–309

https://doi.org/10.26800/LV-147-7-8-8

Andrea Vukić Dugac, Lorna Stemberger Marić, Marija Kusulja, Marija Santini, Miroslav Samaržija, Neven Miculinić

Preuzmi PDF